Multiobjective decision-support tools for the choice between single-use and multi-use technologies in sterile filling of biopharmaceuticals
暂无分享,去创建一个
[1] N. Allison,et al. Extractables and leachables issues with the application of single use technology in the biopharmaceutical industry , 2016 .
[2] Konrad Hungerbühler,et al. Activity Modeling for Integrating Environmental, Health and Safety (EHS) Consideration as a New Element in Industrial Chemical Process Design , 2008 .
[3] Xuewen Tao,et al. Riemann Kernel Support Vector Machine Recursive Feature Elimination in the Field of Compound Limb Motor Imagery BCI , 2019, Journal of Mechanical Engineering.
[4] Craig Sandstrom. Disposable vs. Traditional Equipment ― A Facility-Wide View , 2009 .
[5] Suzanne S Farid,et al. Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.
[6] Georg Müller,et al. Reducing Energy Consumption in Pharmaceutical Production Processes: Framework and Case Study , 2014, Journal of Pharmaceutical Innovation.
[7] Uwe Gottschalk,et al. Single-use disposable technologies for biopharmaceutical manufacturing. , 2013, Trends in biotechnology.
[8] Masahiko Hirao,et al. Risk Evaluation Models for the Design of Parenterals Manufacturing Processes , 2017 .
[9] Edward L Cussler,et al. Diffusion: Mass Transfer in Fluid Systems , 1984 .
[10] Jason Walther,et al. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. , 2015, Journal of biotechnology.
[11] A. I. Johnson,et al. Mass transfer studies in an agitated vessel , 1956 .
[12] Konrad Hungerbühler,et al. Decision framework for chemical process design including different stages of environmental, health, and safety assessment , 2008 .
[13] Howard L. Levine,et al. Efficient, Flexible Facilities for the 21st Century , 2012 .
[14] R A Ford,et al. Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.
[15] Suzanne S Farid,et al. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture , 2017, Biotechnology progress.
[16] Gintaras V. Reklaitis,et al. Simulation-optimization approach to clinical trial supply chain management with demand scenario forecast , 2012, Comput. Chem. Eng..
[17] Masahiko Hirao,et al. Erratum to: Decision-Support Method for the Choice Between Single-Use and Multi-Use Technologies in Sterile Drug Product Manufacturing , 2017, Journal of Pharmaceutical Innovation.
[18] Veis Šerifi,et al. Functional and Information Modeling of Production Using IDEF Methods , 2009 .
[19] Andrew Sinclair,et al. An environmental life cycle assessment comparison of single-use and conventional process technology for the production of monoclonal antibodies , 2013 .
[20] Weibing Ding,et al. Determination of Extractables and Leachables from Single‐Use Systems , 2013 .
[21] Rick Ng. Drugs: From Discovery to Approval , 2004 .
[22] Wei Wang,et al. Impact of residual impurities and contaminants on protein stability. , 2014, Journal of pharmaceutical sciences.
[23] D. Jenke,et al. Extractables/leachables from plastic tubing used in product manufacturing. , 2006, International journal of pharmaceutics.
[24] Bruce Rawlings,et al. Environmental Impact of Single-Use and Reusable Bioprocess Systems , 2009 .